$4.23
Closed
-$0.01(-0.35%)

At close

About

American Vanguard Corp. is a holding company which engages in the development and marketing of specialty and agricultural products for crop protection and management, turf and ornamentals management, public and animal health. The company is headquartered in Newport Beach, California and currently employs 845 full-time employees. The firm develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. The firm conducts its business through its operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC manufactures chemical, biological and biorational products that develop and markets solutions for agricultural, commercial and consumer uses. Its products include insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals, and are marketed in liquid, powder, and granular forms. AMVAC BV sells products both directly and through its network of subsidiaries in various international territories. The company also manufactures microbial cleaning products, BioMop-Plus and DrainGel.
Country

US

CEO

Mr. Douglas Kaye

IPO date

1987

Employees

845

ISIN

US0303711081

Key stats

Open

$5.47

Volume

325.57K

Market cap

$122.35M

Prev. close

$4.25

Impl / hst vl

-

Open interest

$0.00

$0.00

Day’s Range

$0.00

$3.28

52W Range

$12.66

Valuation

50
Valuation score
Fairly Valued
P/E
-
P/S
0.27
P/B
0.46
Current ratio
1.89
Debt / Equity
0.51
ROE
-8.13%
Gross margin
14.62%
Income growth
119.62%
FCF growth
-257.47

Jul

10

Dividends

The last payment date was Jul 10, 2024

Div. per Share

$0.03

Div. Yield

8.84%

Payout Ratio

-

Div. Growth YoY

-

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$14.28
The top 2 analysts forecasts that 12-month price may increase by 237.59%, with a low of $14.14 and a high of $14.70
$14.14
Low
$14.28
Avg
$14.70
High
Current price

Earnings

Q3 ‘24 revenue
$118.31M
Q3 ‘24 net income
-$25.74M
Revenue
Net income
Previous EPS
-
Estimate EPS
$0.03
Actual EPS
Estimate EPS